SCHEMBL4521385

SCHEMBL4521385

COc1cccc(-n2nc(C(C)(C)C)cc2N(C(=O)O)c2ccc([N+](=O)[O-])cc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 8/20 0.48
MAPK13 O15264 2/20 0.48
MAPK12 P53778 2/20 0.48
MAPK11 Q15759 2/20 0.48
DDR2 Q16832 2/20 0.42
ABCG2 Q9UNQ0 2/20 0.40
RIPK2 O43353 1/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
SLC16A3 O15427 1/20 0.38
SLC16A1 P53985 1/20 0.38
ELANE P08246 1/20 0.38
GRN P28799 1/20 0.38
SORT1 Q99523 1/20 0.38
MAPT P10636 1/20 0.38
AHR P35869 1/20 0.38
NPC1 O15118 1/20 0.38
ABL1 P00519 1/20 0.38
KIT P10721 1/20 0.38
ABHD16A O95870 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4521378 1.00 MAPK14 (0.48) MAPK14MAPK13MAPK12MAPK11DDR2
SCHEMBL4497925 0.89 MAPK14 (0.48) MAPK14MAPK13MAPK12MAPK11DDR2
SCHEMBL4521041 0.89 MAPK14 (0.49) MAPK14MAPK13MAPK12MAPK11DDR2
SCHEMBL4521030 0.89 MAPK14 (0.49) MAPK14MAPK13MAPK12MAPK11DDR2
SCHEMBL4520797 0.88 MAPK14 (0.46) MAPK14DDR2GRNSORT1ABL1
SCHEMBL4520800 0.88 MAPK14 (0.46) MAPK14DDR2GRNSORT1ABL1
SCHEMBL4504911 0.84 MAPK14 (0.45) MAPK14MAPK13MAPK12MAPK11KMT2A
SCHEMBL4146349 0.77 MAPK14 (0.44) MAPK14MAPK13MAPK12MAPK11DDR2
SCHEMBL4513085 0.76 MEN1 (0.38) MAPK14DDR2MEN1KMT2AMAPT
SCHEMBL4513082 0.76 MEN1 (0.38) MAPK14DDR2MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270350-A1 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives PFIZER INC. 2009-10-29 US disclosed
EP-1987022-A1 PYRIDINONE PYRAZOLE UREA AND PYRIMIDINONE PYRAZOLE UREA DERIVATIVES Pfizer Products Inc. (US) 2008-11-05 EP disclosed
WO-2007091176-A1 PYRIDINONE PYRAZOLE UREA AND PYRIMIDINONE PYRAZOLE UREA DERIVATIVES PFIZER PRODUCTS INC. (US) 2007-08-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270350-A1 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives PDXK, UMPS, CDK2 MAPK14 117/4885MAPK13 130/4885MAPK12 178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.